BioCardia Announces Issuance of Two Patents Related to Technology That Guides Interventional Therapies
April 04, 2023 07:00 ET
|
BioCardia, Inc.
SUNNYVALE, Calif., April 04, 2023 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...